Publications

Journal Article Ppublish 431 citations
Electronic publication date
September 8, 2012

View on Pubmed.gov 22664874 | View on doi.org 10.4049/jimmuno...

Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway.

Search for publications in this journal J Immunol - 189(1):444-53

  • Xian-zong Ye

    Search for this expert
    1
  • Sen-lin Xu
  • Yan-hong Xin

    Search for this expert
  • Shi-cang Yu
  • Yi-fang Ping

    Search for this expert
  • Lu Chen

    Search for this expert
  • Hua-liang Xiao

    Search for this expert
  • Bin Wang

    Search for this expert
  • Liang Yi

    Search for this expert
  • Qing-liang Wang

    Search for this expert
  • Xue-feng Jiang

    Search for this expert
  • Lang Yang

    Search for this expert
  • Peng Zhang

    Search for this expert
  • Cheng Qian

    Search for this expert
  • You-hong Cui

    Search for this expert
  • Xia Zhang

    Search for this expert
  • Xiu-wu Bian

    Search for this expert

Abstract

The invasion of malignant glioma cells into the surrounding normal brain tissues is crucial for causing the poor outcome of this tumor type. Recent studies suggest that glioma stem-like cells (GSLCs) mediate tumor invasion. However, it is not clear whether microenvironment factors, such as tumor-associated microglia/macrophages (TAM/Ms), also play important roles in promoting GSLC invasion. In this study, we found that in primary human gliomas and orthotopical transplanted syngeneic glioma, the number of TAM/Ms at the invasive front was correlated with the presence of CD133(+) GSLCs, and these TAM/Ms produced high levels of TGF-β1. CD133(+) GSLCs isolated from murine transplanted gliomas exhibited higher invasive potential after being cocultured with TAM/Ms, and the invasiveness was inhibited by neutralization of TGF-β1. We also found that human glioma-derived CD133(+) GSLCs became more invasive upon treatment with TGF-β1. In addition, compared with CD133(-) committed tumor cells, CD133(+) GSLCs expressed higher levels of type II TGF-β receptor (TGFBR2) mRNA and protein, and downregulation of TGFBR2 with short hairpin RNA inhibited the invasiveness of GSLCs. Mechanism studies revealed that TGF-β1 released by TAM/Ms promoted the expression of MMP-9 by GSLCs, and TGFBR2 knockdown reduced the invasiveness of these cells in vivo. These results demonstrate that TAM/Ms enhance the invasiveness of CD133(+) GSLCs via the release of TGF-β1, which increases the production of MMP-9 by GSLCs. Therefore, the TGF-β1 signaling pathway is a potential therapeutic target for limiting the invasiveness of GSLCs.

References

No references provided.

Cited by 431 citations (total)

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

On the role of 25-hydroxycholesterol synthesis by glioblastoma cell lines. Implications for chemotactic monocyte recruitment.

Electronic publication date September 10, 2013

Search for publications in this journal Exp Cell Res

Gerald Eibinger [...] Wolfgang Sattler et al.

Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor and is invariably fatal to affected patients. Oxysterols belong...

Journal Article Review

The controversial role of microglia in malignant gliomas.

Electronic publication date February 18, 2014

Search for publications in this journal Clin Dev Immunol

Jun Wei [...] Amy Heimberger et al.

Malignant gliomas contain stroma and a variety of immune cells including abundant activated microglia/macrophages. Mounting evidence indicates that the glioma...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances